Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 501–600 of 2,099
Yaluri, N., Modi, S., & Kokkola, T. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.026 · Cited by 41
“Impaired insulin-stimulated glycogen synthesis has been found in patients with T2D and persons at the risk of the disease [26].”
BackgroundDose–response effects of exercise on insulin among colon cancer survivors
Brown, J. C., Rickels, M. R., Troxel, A. B., Zemel, B. S., Damjanov, N., Ky, B., Rhim, A. D., Rustgi, A. K., Courneya, K. S., & Schmitz, K. H. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0377 · Cited by 42
“We hypothesize that alterations in skeletal muscle insulin resistance and free fatty acid (FFA) metabolism may help to further explain this effect (DeFronzo & Tripathy 2009, Abdul-Ghani & DeFronzo 2010).”
Lin, C., Kuo, Y., & Shih, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112314 · Cited by 37
In Defense of Sugar: A Critique of Diet-Centrism
Archer, E. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.04.007 · Cited by 42
Bioengineered in vitro 3D model of myotonic dystrophy type 1 human skeletal muscle
Fernández‐Garibay, X., Ortega, M. A., Cerro-Herreros, E., Comelles, J., Martínez, E., Artero, R. D., Fernández‐Costa, J. M., & Ramón‐Azcón, J. (2021) · Biofabrication · doi:10.1088/1758-5090/abf6ae · Cited by 43
“This tissue can be affected by several neuromuscular or metabolic disorders, such as myasthenia gravis [2], McArdle disease [3], type 2 diabetes [4, 5], and muscular dystrophies [6].”
BackgroundVieira‐Lara, M. A., Dommerholt, M. B., Zhang, W., Blankestijn, M., Wolters, J. C., Abegaz, F., Gerding, A., van der Veen, Y. T., van Dijk, T. H., van Os, R. P., et al. (2021) · BMC Biology · doi:10.1186/s12915-021-01082-5 · Cited by 40
“whole-body glucose homeostasis, skeletal muscle IR precedes the onset of type 2 diabetes [2].”
BackgroundOuyang, J., Cai, Y., Song, Y., Gao, Z., Bai, R., & Wang, A. (2022) · Nutrients · doi:10.3390/nu14224933 · Cited by 36
Llanos, P., & Palomero, J. (2022) · Cells · doi:10.3390/cells11244008 · Cited by 43
“Skeletal muscle tissue is critical for maintaining glucose due to its mass and high rate of metabolism, and thus, it is an important tissue in the context of impaired glucose homeostasis [49].”
BackgroundXiao, N., Ding, Y., Cui, B., Li, R., Qu, X.-R., Zhou, H., Au, K.-H., Fan, X.-D., Xie, J.-C., Huang, Y., et al. (2024) · The Innovation Medicine · doi:10.59717/j.xinn-med.2024.100090 · Cited by 43
Gallwitz, B., KAZDA, C. M., Kraus, P., Nicolay, C., & Schernthaner, G. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0319-4 · Cited by 40
“However, impaired beta-cell function often follows obesity-related insulin resistance, which could also suggest that insulin resistance is the primary defect [16], although it may be that both factors are involved in the early stages of diabetes [17].”
BackgroundWu, C. J., Chen, X., Shu, J., & Lee, C. (2017) · Oncotarget · doi:10.18632/oncotarget.16118 · Cited by 39
“We have previously performed extensive bioinformatics analyses using the GTEx database and successfully demonstrated that type 2 diabetic skeletal muscle is characterized by insulin resistance [10], which is considered to be the primary defect involved in T2DM [11].”
MethodTunduguru, R., Zhang, J., Aslamy, A., Salunkhe, V. A., Brozinick, J. T., Elmendorf, J. S., & Thurmond, D. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.801340 · Cited by 35
“Skeletal muscle accounts for 80% of insulin-dependent postprandial glucose uptake (3, 4); skeletal muscle insulin resistance contributes to the development of type 2 diabetes (5).”
Gundersen, A. E., Kugler, B. A., McDonald, P. M., Veraksa, A. N., Houmard, J. A., & Zou, K. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2019-0208 · Cited by 37
N-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications
Salek, M., Clark, C. C. T., Taghizadeh, M., & Jafarnejad, S. (2019) · EXCLI journal · doi:10.17179/excli2019-1534 · Cited by 34
Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)
Brown, J. C., Zhang, S., Ou, F., Venook, A. P., Niedzwiecki, D., Lenz, H., Innocenti, F., O’Neil, B. H., Shaw, J. E., Polite, B. N., et al. (2019) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz078 · Cited by 40
“The biologic hallmark of type 2 diabetes is insulin resistance and hyperglycemia (10).”
BackgroundType 2 diabetes – unmet need, unresolved pathogenesis, mTORC1-centric paradigm
Bar‐Tana, J. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09545-w · Cited by 44
Workeneh, B., Moore, L. W., Fong, J. N., Shypailo, R. J., Gaber, A. O., & Mitch, W. E. (2019) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2019.01.009 · Cited by 41
N-Doped Carbon Nanorods from Biomass as a Potential Antidiabetic Nanomedicine
Park, M., Sharma, A., Kang, C., Han, J.-Y., Tripathi, K. M., & Lee, H. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c01598 · Cited by 40
Sarcopenia and type 2 diabetes: Pathophysiology and potential therapeutic lifestyle interventions
Marcotte‐Chénard, A., Oliveira, B., Little, J. P., & Candow, D. G. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102835 · Cited by 47
Sato, S., Ogura, Y., Tajrishi, M. M., & Kumar, A. (2014) · The FASEB Journal · doi:10.1096/fj.14-260703 · Cited by 34
“Theglucose tolerance test (GTT)and insulin tolerance test (ITT) were performed following a method as previously described (5).”
BackgroundMethodKandhare, A. D., Bodhankar, S. L., Mohan, V., & Thakurdesai, P. A. (2015) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2015.50307 · Cited by 34
“Skeletal muscle is primary site for IR because insulin-stimulated glucose uptake takes place in skeletal muscle (DeFronzo and Tripathy, 2009).”
BackgroundType 2 Diabetes is a Delayed Late Effect of Whole-Body Irradiation in Nonhuman Primates
Kavanagh, K., Dendinger, M. D., Davis, A., Register, T. C., DeBo, R. J., Dugan, G. O., & Cline, J. M. (2015) · Radiation Research · doi:10.1667/rr13916.1 · Cited by 40
“muscle metabolizes approximately 90% of circulating glucose (6), however, our nondiabetic monkey groups differed in muscle mass, but not necessarily glucose”
Paing, A. C., McMillan, K. A., Kirk, A. F., Collier, A., Hewitt, A., & CHASTIN, S. F. M. (2018) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2018.09.002 · Cited by 45
“Skeletal muscle is one of the major sites for glucose metabolism (Sinacore and Gulve, 1993; DeFronzo and Tripathy, 2009; Dunstan et al., 2007).”
BackgroundLin, X., Parker, L., McLennan, E. D., Hayes, A., McConell, G. K., Brennan‐Speranza, T. C., & Levinger, I. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3731 · Cited by 39
“(1,2) However, recent evidence suggests that even short‐term administration of GCs results in the development of skeletal muscle insulin resistance: the initiating and primary defect of T2DM.”
Hofstee, P., McKeating, D. R., Bartho, L. A., Anderson, S. T., Perkins, A. V., & Cuffe, J. S. M. (2020) · Nutrients · doi:10.3390/nu12010267 · Cited by 36
The phospholipase A2 family’s role in metabolic diseases: Focus on skeletal muscle
Cervera, I. P., Gabriel, B. M., Aldiss, P., & Morton, N. M. (2021) · Physiological Reports · doi:10.14814/phy2.14662 · Cited by 35
Mediators of Metabolism: An Unconventional Role for NOD1 and NOD2
Zangara, M. T., Johnston, I., Johnson, E. E., & McDonald, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031156 · Cited by 37
The Role of Glutathione and Its Precursors in Type 2 Diabetes
Tuell, D. S., Ford, G., LOS, E. A., & Stone, W. L. (2024) · Antioxidants · doi:10.3390/antiox13020184 · Cited by 43
Claycombe, K., Roemmich, J. N., Johnson, L. K., Vomhof‐DeKrey, E. E., & Johnson, W. T. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.10.003 · Cited by 36
“Skeletal muscle is the major glucose utilizing tissue, and resting muscle glucose uptake is mediated by insulin [8].”
BackgroundChowdhury, A., Kunjiappan, S., Bhattacharjee, C., Somasundaram, B., & Theivendren, P. (2017) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-017-0136-3 · Cited by 38
Lai, N., Kummitha, C. M., & Hoppel, C. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183978 · Cited by 33
Sweeney, E. L., Jeromson, S., Hamilton, D. L., Brooks, N. E., & Walshe, I. H. (2017) · Physiological Reports · doi:10.14814/phy2.13498 · Cited by 218
“Previous research suggests that a chronic increase in circulating insulin can lead to impaired insulin signaling within skeletal muscle, which is thought to be the initial defect leading to insulin resistance and the development of type 2 diabetes (DeFronzo and Tripathy 2009).”
BackgroundKim, H., Lee, M. J., Kim, E., Bae, S.-J., Choe, J., Kim, C., & Park, J. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0141 · Cited by 33
Tammineni, E. R., Kraeva, N., Figueroa, L., Manno, C. D., Ibarra, C. A., Klip, A., Riazi, S., & Ríos, E. (2020) · eLife · doi:10.7554/elife.53999 · Cited by 38
“Muscle is critical to glucose homeostasis, to the point that its failure to take up glucose heralds the eventual onset of type 2 diabetes (DeFronzo and Tripathy, 2009).”
BackgroundSmall intestinal metabolism is central to whole-body insulin resistance
Angelini, G., Salinari, S., Castagneto‐Gissey, L., BERTUZZI, A., Casella-Mariolo, J. R., Ahlin, S., Boškoski, I., Gaggini, M., Raffaelli, M., Costamagna, G., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-322073 · Cited by 35
Pyun, D. H., Kim, T. J., Park, S. Y., Lee, H. J., El‐Aty, A. M. A., Jeong, J. H., & Jung, T. W. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111464 · Cited by 35
Zhang, Q., Li, R., Wang, L., Zhang, T., Qian, D., Tang, D., He, C., Wu, C., & Li, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1089558 · Cited by 34
“Insulin resistance is considered the predominant contributing factor in T2DM, which is mainly caused by obesity, sedentary lifestyle, and increasing life span (DeFronzo and Tripathy, 2009).”
BackgroundRabbani, N., & Thornalley, P. J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1268308 · Cited by 44
Wood, R. J., & O’Neill, E. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/268197 · Cited by 39
“In muscle tissue, dysfunction occurs with insulin sensitivity [3], mitochondrial function [6], and an accumulation of triglycerides [4, 5].”
BackgroundMethodInfluentialSilverstein‐Metzler, M. G., Ordanes, D., Wylie, A. T., Files, D. C., Milligan, C., Presley, T. D., & Kavanagh, K. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu119 · Cited by 36
“Improvements in glycemic control are likely to reflect preservation of muscle metabolic function (26) as muscle takes up ~90% of circulating glucose (29).”
BackgroundProteomics of Skeletal Muscle: Focus on Insulin Resistance and Exercise Biology
Deshmukh, A. S. (2016) · Proteomes · doi:10.3390/proteomes4010006 · Cited by 38
“Skeletal muscle insulin resistance is a hallmark feature of Type 2 diabetes [65,66].”
BackgroundKeapai, W., Apichai, S., Amornlerdpison, D., & Lailerd, N. (2016) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2016.20.6.581 · Cited by 34
“Insulin resistance, the hallmark feature of T2DM, is characterized by a decreased insulin-stimulated glucose uptake due to impaired insulin signaling [3,4].”
BackgroundInfluentialEid, H. M., Thong, F. S. L., Nachar, A., & Haddad, P. S. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1345952 · Cited by 38
“In skeletal muscle, which is responsible for about 75% of postprandial glucose uptake, AMPK regulates glucose uptake through activation of GLUT4 translocation from intracellular pools to plasma membrane (DeFronzo and Tripathy 2009).”
BackgroundCastagneto‐Gissey, L., Mariolo, J. R. C., & Mingrone, G. (2018) · Peptides · doi:10.1016/j.peptides.2017.12.010 · Cited by 36
“This suggests that the duodenum and the jejunum play a role in insulin resistance, which is considered as the major finding of type 2 diabetes [65].”
The exocyst complex regulates insulin-stimulated glucose uptake of skeletal muscle cells
Fujimoto, B., Young, M., CARTER, L. T., Pang, A. P. S., Corley, M. J., Fogelgren, B., & Polgár, N. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00109.2019 · Cited by 38
“Insulin resistance in skeletal muscle is a principle component in the pathophysiology of type 2 diabetes mellitus (14).”
BackgroundLuan, H., Huo, Z., Zhao, Z., Zhang, S., Huang, Y., Shen, Y., Wang, P., Xi, J., Liang, J., & Wu, F. (2019) · Phytotherapy Research · doi:10.1002/ptr.6582 · Cited by 35
Wood, N., Straw, S., Scalabrin, M., Roberts, L. D., Witte, K. K., & Bowen, T. S. (2020) · ESC Heart Failure · doi:10.1002/ehf2.13121 · Cited by 33
“Insulin resistance is considered one major defect in the pathology of DM in humans.(80) Insulin sensitivity is also known to be lower in HF patients without DM and has been linked to reductions in both muscle quantity and function.”
BackgroundMuscle and Adipose Tissue Communicate with Extracellular Vesicles
Rome, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137052 · Cited by 36
Neuregulin 1 improves glucose tolerance in adult and old rats
Caillaud, K., Boisseau, N., Ennequin, G., Chavanelle, V., Etienne, M., Li, X., Denis, P., Dardevet, D. P., Lacampagne, A., & Sirvent, P. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.08.003 · Cited by 32
A Critically Swift Response: Insulin-Stimulated Potassium and Glucose Transport in Skeletal Muscle
Ho, K. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04540511 · Cited by 32
“(2) show in this issue of CJASN that the reduced glucose uptake in skeletal muscle, characteristic of insulin resistance in patients with type 2 diabetes (3), is not associated with a parallel decrement in cellular potassium and phosphate uptake.”
BackgroundCarbohydrate restriction: Friend or foe of resistance-based exercise performance?
Cholewa, J. M., Newmire, D. E., & Zanchi, N. E. (2019) · Nutrition · doi:10.1016/j.nut.2018.09.026 · Cited by 32
WWOX somatic ablation in skeletal muscles alters glucose metabolism
Abu‐Remaileh, M., Abu-Remaileh, M., Akkawi, R., Knani, I., Udi, S., Pacold, M. E., Tam, J., & Aqeilan, R. I. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.01.010 · Cited by 31
TNIK is a conserved regulator of glucose and lipid metabolism in obesity
Pham, T. C. P., Dollet, L., Ali, M. S., Raun, S. H., Møller, L. L. V., Jafari, A., Ditzel, N., Andersen, N. R., Fritzen, A. M., Gerhart‐Hines, Z., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf7119 · Cited by 37
“Insulin-stimulated skeletal muscle glucose uptake is increased by loss of TNIK Skeletal muscle is a major tissue in whole-body glucose metabolism, and skeletal muscle insulin resistance contributes to the development of T2D (22).”
BackgroundMulti-omics approaches for biomarker discovery and precision diagnosis of prediabetes
Song, J., Wang, C., Zhao, T., Zhang, Y., Xing, J., Zhao, X., Zhang, Y., & Zhang, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1520436 · Cited by 53
“Consequently, alterations in skeletal muscle composition regarding fat content and lipid distribution may serve as critical determinants of IR (222).”
Adiponectin and insulin cross talk: The microvascular connection
Zhao, L., Fu, Z., & Liu, Z. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.08.001 · Cited by 38
“Skeletal muscle is a major organ regulating body energy metabolism and accounts for approximately 80% of insulinstimulated whole-body glucose disposal during euglycemic insulin clamp [47].”
BackgroundKain, V., Kapadia, B. B., Viswakarma, N., Seshadri, S., Prajapati, B., Jena, P. K., Meda, C. L. T., Subramanian, M., Suraj, S. K., Kumar, S. T., et al. (2015) · Scientific Reports · doi:10.1038/srep15197 · Cited by 35
Li, B., Guo, J., Xi, Z., Xu, J., Zuo, Z., & Wang, C. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1961-6 · Cited by 35
“Insulin resistance in skeletal muscle, liver, and adipose tissue plays a crucial role in the occurrence of glucose intolerance and T2DM (Capozza et al.”
BackgroundInfluentialThe regulation of skeletal muscle fiber-type composition by betaine is associated with NFATc1/MyoD
Du, J., Shen, L., Zhang, P., Tan, Z., Xiao, C., Luo, J., Zhao, X., Yang, Q., Gu, H., Jiang, A., et al. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1657-2 · Cited by 46
Cheng, Q., Li, Y. W., Yang, C., Zhong, Y., & Li, L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00949 · Cited by 31
Effects of Resveratrol in Goto-Kakizaki Rat, a Model of Type 2 Diabetes
Szkudelska, K., Deniziak, M., Hertig, I., Wojciechowicz, T., Tyczewska, M., Jaroszewska, M., & Szkudelski, T. (2019) · Nutrients · doi:10.3390/nu11102488 · Cited by 32
“Moreover, insulin resistance in the skeletal muscle is thought to be the primary defect in type 2 diabetes [31], whereas reduced lipid accumulation in this tissue, with a concomitant improvement of intramuscular glucose transport, positively affects whole-body glucose homeostasis [32,33].”
BackgroundPrevalence and Predictors of Insulin Resistance in Non-Obese Healthy Young Females in Qatar
Elrayess, M. A., Rizk, N. M., Fadel, A., & Kerkadi, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17145088 · Cited by 34
Kim, E., Cui, J., Kang, I., Zhang, G., & Lee, Y. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031367 · Cited by 35
“The amount of glucose uptake by skeletal muscles constitutes the majority of that taken up by the whole body (more than 80%) [51,52].”
Potential Application of Some Lamiaceae Species in the Management of Diabetes
Etsassala, N. G. E. R., Hussein, A. A., & Nchu, F. (2021) · Plants · doi:10.3390/plants10020279 · Cited by 37
Role of Sphingosine Kinase in Type 2 Diabetes Mellitus
Qi, Y., Wang, W., Song, Z., Aji, G., Liu, X. T., & Xia, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.627076 · Cited by 37
“In both postprandial state and the hyperinsulinemic-euglycemic clamp experiments, skeletal muscle uptakes approximately 80% of blood glucose (100, 101).”
BackgroundXu, Y., Hu, T., Shen, Y., Wang, Y., Bao, Y., & Ma, X. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01027-8 · Cited by 37
Association between whole blood mercury and glucose intolerance among adult Inuit in Greenland
Jeppesen, C., Valéra, B., Nielsen, N. O., Bjerregaard, P., & Jørgensen, M. E. (2015) · Environmental Research · doi:10.1016/j.envres.2015.10.013 · Cited by 33
Neonatal overnutrition in mice exacerbates high-fat diet-induced metabolic perturbations
Liu, Z., Lim, C. Y., Su, M. Y.-F., Soh, S. L., Shui, G., Wenk, M. R., Grove, K. L., Radda, G. K., Han, W., & Xiao, X. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0111 · Cited by 35
“The impaired SKM insulin signaling is crucial for systemic insulin resistance and precedes the development of diabetes (DeFronzo & Tripathy 2009, Pagel-Langenickel et al. 2010).”
BackgroundViscarra, J. A., Rodríguez, R., Vázquez‐Medina, J. P., Lee, A., Tift, M. S., Tavoni, S. K., Crocker, D. E., & Ortiz, R. M. (2013) · Physiological Reports · doi:10.1002/phy2.23 · Cited by 36
Burned Adults Develop Profound Glucose Intolerance
Rehou, S., Mason, S. A., Burnett, M., & Jeschke, M. G. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001605 · Cited by 31
“Insulin resistance is defined as a reduced response to insulin (9), resulting in reduced glucose uptake in the presence of insulin.”
BackgroundMethodIntramyocellular fat storage in metabolic diseases
Laurens, C., & Moro, C. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0045 · Cited by 41
“Skeletal muscle plays a major role in whole body glucose homeostasis, as it is responsible for 80% of glucose disposal in response to insulin in the postprandial phase [14, 15].”
BackgroundAntinozzi, C., Corinaldesi, C., Giordano, C., Pisano, A., Cerbelli, B., Migliaccio, S., Luigi, L. D., Stefanantoni, K., Vannelli, G. B., Minisola, S., et al. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.12.010 · Cited by 36
O'Harte, F. P. M., Parthsarathy, V., Hogg, C., & Flatt, P. R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.10.002 · Cited by 35
Rho GTPases in Skeletal Muscle Development and Homeostasis
Rodríguez‐Fdez, S., & Bustelo, X. R. (2021) · Cells · doi:10.3390/cells10112984 · Cited by 35
The bidirectional associations between sarcopenia-related traits and cognitive performance
Lu, C., Liu, W., Cang, X., Sun, X., Wang, X., Wang, C., & Xu, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-58416-w · Cited by 41
“Skeletal muscle is also the core metabolic tissue where insulin functions, and the loss of both skeletal muscle mass and function can significantly promote insulin resistance 44 .”
BackgroundDomin, H., & Śmiałowska, M. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105748 · Cited by 34
Adipose Tissue Insulin Resistance: A Key Driver of Metabolic Syndrome Pathogenesis
Rabiee, A., Hossain, M. A., & Poojari, A. (2025) · Biomedicines · doi:10.3390/biomedicines13102376 · Cited by 64
“It can be detected early, offering an intervention window [4,5].”
Reassessing the Role of Diacylglycerols in Insulin Resistance
Jayasinghe, S. U., Tankeu, A. T., & Amati, F. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.06.005 · Cited by 33
Lewis, M. T., Kasper, J. D., Bazil, J. N., Frisbee, J. C., & Wiseman, R. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215271 · Cited by 38
Truong, C.-S., Seo, E., & Jun, H. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4310319 · Cited by 31
“Insulin resistance is generally defined as a reduced response of target tissues, such as the skeletal muscle, liver, and adipocytes, to insulin [3].”
BackgroundThe essential role of fructose-1,6-bisphosphatase 2 enzyme in thermal homeostasis upon cold stress
Park, H., Jang, H. R., Park, S., Kim, Y., Lee, H., & Choi, C. S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0402-4 · Cited by 34
Tamura, Y., Kouzaki, K., Kotani, T., & Nakazato, K. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00494.2019 · Cited by 39
Koh, H. E., van Vliet, S., Meyer, G. A., Laforest, R. A., Gropler, R. J., Klein, S., & Mittendorfer, B. (2021) · Diabetologia · doi:10.1007/s00125-021-05383-w · Cited by 34
ALY688 elicits adiponectin-mimetic signaling and improves insulin action in skeletal muscle cells
Sung, H. K., Mitchell, P. L., Gross, S. M., Marette, A., & Sweeney, G. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00603.2020 · Cited by 32
Association between sarcopenia and prediabetes among non-elderly US adults
Xu, J., Han, X., Chen, Q., Cai, M., Tian, J., Yan, Z., Guo, Q., Xu, J., & Lü, H. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02038-y · Cited by 35
“Previous study showed that skeletal insulin resistance was a vital link between sarcopenia and dysglycemia [32], and the mechanism might involve mitochondrial dysfunction in skeletal muscle, enhanced oxidative stress response, dysregulated myokine secretion, and chronic lowgrade inflammation [33–35].”
BackgroundTuell, D. S., LOS, E. A., Ford, G. A., & Stone, W. L. (2023) · Antioxidants · doi:10.3390/antiox12061139 · Cited by 36
“Insulin resistance in skeletal muscle is considered the initiating, or primary, defect leading to T2D [15].”
BackgroundEffects of walking on low-grade inflammation and their implications for Type 2 Diabetes
Morettini, M., Storm, F. A., Sacchetti, M., Cappozzo, A., & Mazzà, C. (2015) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2015.06.012 · Cited by 39
“The activation of the described inflammatory pathway appears to be linked to the onset of insulin resistance (Yudkin et al., 1999) in the peripheral tissues, namely the skeletal muscle and adipose tissue, which is an early factor of the pathogenesis of T2D (DeFronzo and Tripathy, 2009).”
BackgroundFas (CD95) expression in myeloid cells promotes obesity‐induced muscle insulin resistance
Wueest, S., Mueller, R., Blüher, M., Item, F., Chin, A. S. H., Wiedemann, M. S. F., Takizawa, H., Kovtonyuk, L. V., Chervonsky, A. V., Schoenle, E. J., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302962 · Cited by 33
“In fact, skeletal muscle insulin resistance is an early metabolic alteration that frequently precedes type 2 diabetes (DeFronzo & Tripathy, 2009).”
GH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice
Biagetti, B., & Simó, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010415 · Cited by 28
Collins, K. A., Ross, L. M., Slentz, C. A., Huffman, K. M., & Kraus, W. E. (2022) · Sports Medicine - Open · doi:10.1186/s40798-022-00480-5 · Cited by 43
“, decreased sensitivity); and (3) abnormalities in splanchnic glucose uptake [5, 6].”
BackgroundLuo, C., Liu, R., Zhang, G.-W., Hu, F., Jin, Y., & Liu, B. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04104-9 · Cited by 31
“Furthermore, sarcopenia is associated with insulin resistance [36], which is considered to be the main defect in T2DM development [37].”
BackgroundGrowing healthy muscles to optimise metabolic health into adult life
Bayol, S. A., Bruce, C. R., & Wadley, G. D. (2014) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174414000452 · Cited by 35
Fitness, Body Habitus, and the Risk of Incident Type 2 Diabetes Mellitus in Korean Men
Jae, S. Y., Franklin, B. A., Choo, J., Yoon, E. S., Choi, Y.-H., & Park, W. H. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.11.046 · Cited by 29
Fatty acid oxidation alleviates the energy deficiency caused by the loss of MPC1 in MPC1+/− mice
Zou, S., Lang, T., Zhang, B., Huang, K., Gong, L., Luo, H., Xu, W., & He, X. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.134 · Cited by 32
Gamboa‐Gómez, C. I., Simental‐Mendía, L. E., Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.03.017 · Cited by 34
Mora‐Rodríguez, R., ORTEGA, J. F., Ramírez-Jiménez, M., Moreno‐Cabañas, A., & Morales‐Palomo, F. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.05.004 · Cited by 34
Role of p110a subunit of PI3-kinase in skeletal muscle mitochondrial homeostasis and metabolism
Li, M. E., Lauritzen, H. P. M. M., O'Neill, B. T., Wang, C., Cai, W., Brandão, B. B., Sakaguchi, M., Tao, R., Hirshman, M. F., Softic, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11265-y · Cited by 33
Diurnal Regulation of Peripheral Glucose Metabolism: Potential Effects of Exercise Timing
Mancilla, R., Krook, A., Schrauwen, P., & Hesselink, M. K. C. (2020) · Obesity · doi:10.1002/oby.22811 · Cited by 34
“While nonoxidative glucose disposal predominantly reflects glucose storage as muscle glycogen or conversion to lactate (24), oxidative glucose disposal is partly determined by mitochondrial oxidative capacity.”
BackgroundAnsari, P., Flatt, P. R., Harriott, P., & Abdel‐Wahab, Y. H. A. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520005085 · Cited by 41
Virtual metabolic human dynamic model for pathological analysis and therapy design for diabetes
Kurata, H. (2021) · iScience · doi:10.1016/j.isci.2021.102101 · Cited by 29
Expression and clinical significance of miR‑1 and miR‑133 in pre‑diabetes
Al‐Kafaji, G., Al-Muhtaresh, H. A., & Salem, A. H. (2021) · Biomedical Reports · doi:10.3892/br.2021.1409 · Cited by 36
“Particularly, insulin resistance in skeletal muscle is considered as the primary defect that is evident years before the development of T2D (26).”
Background
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.